ExodusPoint Capital Management, LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,817,038

-$1,098,689 QoQ

Shares Held

3,384

-39.2% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#164

of 411 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. MDGL ranks #42 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,817,038	3,384	-39.2%	Shares	Sole	2026-08-14
2026-03-31	$2,915,727	5,570	+93.5%	Shares	Sole	2026-05-14
2025-06-30	$870,997	2,878	+8.8%	Shares	Sole	2025-08-13
2024-09-30	$561,321	2,645	-67.6%	Shares	Sole	2024-11-12
2023-09-30	$1,191,978	8,162	+670.0%	Shares	Sole	2023-11-13
2023-03-31	$256,795	1,060	-88.4%	Shares	Sole	2023-05-11
2022-09-30	$596,413	9,177	+142.2%	Shares	Sole	2022-11-10
2022-06-30	$271,216	3,789	+81.4%	Shares	Sole	2022-08-22
2020-09-30	$248,026	2,089	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.